Glucosamine (N-Acetylglucosamine) en gélules

• Un traitement combiné avec de la glucosamine et du sulfate de chondroïtine améliore la polyarthrite rhumatoïde chez le rat en régulant le microbiote intestinal
  

(1) Kessler M.A. Volume changes in the menisci and articular cartilage of runners : an in vivo investigation based on 3-D magnetic resonance imaging. Am J Sports Med. 2006 May ; 34(5):832-6. (2) Poolsup N., et al. Glucosamine long-term treatment and the progression of knee osteoarthritis : systematic review of randomized controlled trials. Ann Pharmacother. 2005 Jun ; 39(6):1080-7. (3) Reginster J.Y. Long-term effects of glucosamine sulphate on osteoarthritis progression : a randomised, placebo-controlled clinical trial. Lancet 2001 Jan 27 ; 357 : 251-56. (4) Ostojic SM. Glucosamine administration in athletes: effects on recovery of acute knee injury. Res Sports Med. 2007 Apr-Jun;15(2):113-24. (5) Yoshimura M. Evaluation of the effect of glucosamine administration on biomarkers for cartilage and bone metabolism in soccer players. Int J Mol Med. 2009 Oct;24(4):487-94. (6) Shmidt EI. [Long-term efficacy and safety of chondroitin sulphate (structum, France) in patients with coxarthrosis]. Ter Arkh. 2007;79(1):65-7. (7) Vangsness CT Jr. A review of evidence-based medicine for glucosamine and chondroitin sulfate use in knee osteoarthritis. Arthroscopy. 2009 Jan;25(1):86-94. (8) Bell GA. Use of glucosamine and chondroitin in relation to mortality. Eur J Epidemiol. 2012 Jul 25. [Epub ahead of print] (9) Brasky TM. Use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort. Cancer Causes Control. 2011 Sep;22(9):1333-42. Epub 2011 Jun 25. (10) Zhang YX. Effects of chondroitin sulfate and glucosamine in adult patients with Kaschin-Beck disease. Clin Rheumatol. 2010 Apr;29(4):357-62. (11) Tat SK. Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study. Arthritis Res Ther. 2007;9(6):R117. (12) Lippiello L. Collagen Synthesis in tenocytes, ligament cells and chondrocytes exposed to a combination of Glucosamine HCl and chondroitin sulfate. Evid Based Complement Alternat Med. 2007 Jun;4(2):219-24. (13) Calamia V. Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes. Arthritis Research & Therapy 2010, 12:R138 ; (14) Clegg DO.Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006 Feb 23;354(8):795-808. (15) Jerosch J. Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids. Int J Rheumatol. 2011; 2011: 969012. (16) Calamia V. Secretome analysis of chondroitin sulfate-treated chondrocytes reveals its anti-angiogenic, anti-inflammatory and anti-catabolic properties. Arthritis Research & Therapy 2012, 14:R202. (17) Burton AF. Decreased incorporation of 14C-glucosamine relative to 3H-N-acétyl-glucosamine in the intestinal mucosa of patients with inflammatory bowel disease. Am J Gastroenterol. 1983 Jan;78(1):19-22. (18) Goodman MJ. Glucosamine synthetase activity of the colonic mucosa in ulcerative colitis and Crohn's disease. Gut, 1977, 18, 219-229 (19) Auricchio S. Mannan and oligomers of N-acetylglucosamine protect intestinal mucosa of celiac patients with active disease from in vitro toxicity of gliadin peptides. Gastroenterology. 1990 Oct;99(4):973-8. (20) Rhodes JM. Unifying hypothesis for inflammatory bowel disease and associated colon cancer: sticking the pieces together with sugar. Lancet 1996; 347: 40. (21) Salvatore S. A pilot study of N-acetyl glucosamine, a nutritional substrate for glycosaminoglycan synthesis, in paediatric chronic inflammatory bowel disease. Aliment Pharmacol Ther. 2000 Dec;14(12):1567-79. (22) Bak YK. Effects of dietary supplementation of glucosamine sulfate on intestinal inflammation in a mouse model of experimental colitis. J Gastroenterol Hepatol. 2014 May;29(5):957-63. (23) Yomogida S. Glucosamine, a naturally occurring amino monosaccharide, suppresses dextran sulfate sodium-induced colitis in rats. Int J Mol Med. 2008 Sep;22(3):317-23. (24) Kantor ED. Use of glucosamine and chondroitin supplements and risk of colorectal cancer. Cancer Causes Control. 2013 Jun;24(6):1137-46 (25) Masuda S. Anti-tumor properties of orally administered glucosamine and N-acetyl-D-glucosamine oligomers in a mouse model. Carbohydr Polym. 2014 Oct 13;111:783-7. (26) Jung CW. Anti-cancer properties of glucosamine-hydrochloride in YD-8 human oral cancer cells: Induction of the caspase-dependent apoptosis and down-regulation of HIF-1?. Toxicol In Vitro. 2012 Feb;26(1):42-50. (27) Brasky TM. Use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort. Cancer Causes Control. 2011 Sep;22(9):1333-42. (1) Uitterlinden EJ. Glucosamine reduces anabolic as well as catabolic processes in bovine chondrocytes cultured in alginate. Osteoarthritis Cartilage. 2007 Nov;15(11):1267-74. (2) Uitterlinden EJ. Glucosamine decreases expression of anabolic and catabolic genes in human osteoarthritic cartilage explants. Osteoarthritis Cartilage. 2006 Mar;14(3):250-7. (3) Shikhman A R. Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis. Ann Rheum Dis 2005;64:89-94 (4) GREVENSTEIN J. Cartilage changes in rats induced by papain and the influence of treatment with N-acetylglucosamine. Acta orthopaedica belgica 1991, vol. 57, no2, pp. 157-161 (5) Talent JM. Pilot study of oral polymeric N-acetyl-D-glucosamine as a potential treatment for patients with osteoarthritis. Clin Ther. 1996 Nov-Dec;18(6):1184-90. (6) Tamai Y. Enhanced healing of cartilaginous injuries by N-acetyl-d-glucosamine and glucuronic acid. Carbohydrate Polymers Volume 54, Issue 2, 1 November 2003, Pages 251–262 (7) Serpi M. Novel phosphoramidate prodrugs of N-acetyl-(D)-glucosamine with antidegenerative activity on bovine and human cartilage explants. J Med Chem. 2012 May 24;55(10):4629-39. (8) McGuigan C. Phosphate prodrugs derived from N-acetylglucosamine have enhanced chondroprotective activity in explant cultures and represent a new lead in antiosteoarthritis drug discovery. J Med Chem. 2008 Sep 25;51(18):5807-12. (9) Shikhman AR. N-Acetylglucosamine Prevents IL-1ß-Mediated Activation of Human Chondrocytes. The Journal of Immunology April 15, 2001 vol. 166 no. 8 5155-5160 (10) Setnikar I. Absorption, distribution and excretion of radioactivity after a single IV or oral administration of [14C] to the rat. Pharmatherapeutica (1984)3: 538-550 (11) Shoji A. Metabolic Disposition of [14C] N-Acetylglucosamine in Rats. Chitin and Chitosan Research (1999) 5 (1) : 43 - 42. (12) Kyoung-Youl L. Subchronic toxicity study of dietary N-acetylglucosamine in F344 rats. Food and Chemical Toxicology Volume 42, Issue 4, April 2004, Pages 687–695 (13) Miwa T. Lack of chronic toxicity or carcinogenicity of dietary N-acetylglucosamine in F344 rats. Food and Chemical Toxicology Volume 47, Issue 2, February 2009, Pages 462–471 (14) Chen JK. N-Acetylglucosamine: Production and Applications. Mar. Drugs 2010, 8(9), 2493-2516 (15) Salvatore S. A pilot study of N-acetyl glucosamine, a nutritional substrate for glycosaminoglycan synthesis, in paediatric chronic inflammatory bowel disease. Alimentary Pharmacology & Therapeutics Volume 14, Issue 12, pages 1567–1579, December 2000 (16) Sayo T. Synergistic Effect of N-Acetylglucosamine and Retinoids on Hyaluronan Production in Huma (17) Tu CX. Exogenous N-acetylglucosamine increases hyaluronan production in cultured human dermal fibroblasts. ARCHIVES OF DERMATOLOGICAL RESEARCH Volume 301, Number 7 (2009), 549-551.n Keratinocytes. Skin Pharmacol Physiol 2004;17:77–83 (18) CHEN RH. Effect of Different Concentrations of Collagen, Ceramides, N-acetyl glucosamine, or Their Mixture on Enhancing the Proliferation of Keratinocytes, Fibroblasts and the Secretion of Collagen and/or the Expression of mRNA of Type I Collagen. Journal of Food and Drug Analysis, Vol. 16, No. 1, 2008, Pages 66-74 (19) KIKUCHI K. Oral N-acetylglucosamine supplementation improves skin conditions of female volunteers: Clinical evaluation by a microscopic three-dimensional skin surface analyzer Journal of applied cosmetology 2002, vol. 20, no2, pp. 143-152 (20) Reyes E. Developments in photoaging: review of N-acetylglucosamine. Piel. 2011 (in press) (21) Mammone T. The effect of N-acetyl-glucosamine on stratum corneum desquamation and water content in human skin. International Journal of Cosmetic Science. Volume 32, Issue 3, page 234, June 2010. (22) Hwang YP. N-Acetylglucosamine suppress collagenases activation in ultraviolet B-irradiated human dermal fibroblasts: Involvement of calcium ions and mitogen-activated protein kinases. Journal of Dermatological Science Volume 63, Issue 2, August 2011, Pages 93–103. (23) Mkhikian H. Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis. Nature Communications 2011. 2, Article number: 334